Disease / condition

Advanced Solid Tumor clinical trials

Free access to 382 studies·10+ countries·Updated daily198 recruiting
382
Total trials
10+
Countries
10+
Sponsors
198
Recruiting
By phase
Phase 1269
Phase 1/260
Early Phase 124
Phase 216
N/A9
By status
Recruiting198
Not yet recruit...111
Completed31
Unknown20
Terminated11
Top countries
China176
United States of America64
Australia16
Japan11
South Korea6
Top sponsors
Jiangsu HengRui Me...9
Novartis Pharmaceu...6
Shanghai YingLi Ph...6
Qilu Pharmaceutica...5
BeiGene4
Recent trials
Latest clinical trials for Advanced Solid Tumor
NCT06421935·Phase 1Not yet recr...
M9466 as Single Agent or in Combination With Tuvusertib in Advanced Solid Tumors (DDRiver 501)
EMD Serono Research & Developm...Germany,United States of America
NCT06413615·Phase 2Not yet recr...
A Study of FDA022-BB05 in Advanced/Metastatic Solid Tumors
Shanghai Fudan-Zhangjiang Bio-...China
NCT06408688·Phase 4Not yet recr...
Safety and Modulation of Adaptive Immunity by Iscador® Qu Viscum Album Extract in Patients With Advanced, Recurrent or Metastatic Cancers Treated With Immune Checkpoint Inhibitors
University Hospital, Basel, Sw...Switzerland
NCT06410703·Phase 1/2Not yet recr...
CAN1012 Combined With PD-1 in Patients With Solid Tumors
Canwell Biotech LimitedChina
NCT06404281·Phase 1Not yet recr...
γδ T-PD-1 Ab Cells in the Treatment of Advanced Solid Tumors
Changzhou No.2 People's Hospit...
NCT06373406·Phase 1/2Recruiting
A Study of MHB036C for Advanced Solid Tumor
Minghui Pharmaceutical (Hangzh...China
NCT06372223·Phase 1Completed
A Food Effect Study of SPH5030 Tablets.
Shanghai Pharmaceuticals Holdi...China
NCT06367751Not yet recr...
Implementation of Liquid Biopsies During Routine Clinical Care in Patients With Advanced Malignancies (LIQPLAT)
University Hospital, Basel, Sw...
NCT06352359·Phase 1Not yet recr...
Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors
OncoC4, Inc.United States of America
NCT06334783·Phase 1Recruiting
TIL for Patients With Advanced Solid Tumor
Hervor TherapeuticsChina
NCT06404905·Phase 1Recruiting
Clinical Trial of BT02 in Patients With Advanced Solid Tumors
Cancer Institute and Hospital,...China
NCT06345482·Phase 1/2Not yet recr...
A Study of MHB039A for Advanced Solid Tumor
Minghui Pharmaceutical (Hangzh...China
NCT06332170·Phase 1Not yet recr...
ARTEMIS-101: A Study of HS-20093 Combinations in Patients With Advanced Solid Tumors
Hansoh BioMedical R&D Company
NCT06307925·Phase 1Recruiting
A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors
HC Biopharma Inc.China
NCT06328673·Phase 1Recruiting
A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors
D2M Biotherapeutics Inc.United States of America
NCT06304571·Phase 1Recruiting
A Study of HC006 in Subjects With Advanced Solid Tumors
HC Biopharma Inc.China
NCT06298058·Phase 1Not yet recr...
A Clinical Trial of SIBP-A13 Injection in the Treatment of Advanced Malignant Solid Tumor Patients.
Shanghai Institute Of Biologic...
NCT06289894·Phase 1Not yet recr...
A Study of BRY805 in Participants With Advanced Solid Tumors
BioRay Pharmaceutical Co., Ltd...China
NCT06258408·Phase 1Recruiting
A Phase 1 Study of BB102 in Participants With Advanced Solid Tumors
BrodenBio Co., Ltd.China
NCT06277219·Phase 1/2Not yet recr...
A First-in-Human, Phase 1/2 Study of LAT010 in Patients With Advanced Solid Tumors (LIGHTSPEED-1)
Latticon Antibody Therapeutics...United States of America
About this record

Access comprehensive clinical trial information for Advanced Solid Tumor through Pure Global AI's free database. This collection includes 382 clinical trials across multiple phases including Phase 1, Phase 1/2, Early Phase 1. Currently, 198 trials are actively recruiting participants.

Research for Advanced Solid Tumor is being conducted in China, United States of America, Australia and 7+ other countries. Leading sponsors include Jiangsu HengRui Medicine Co., Ltd. and Novartis Pharmaceuticals. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 382 clinical trials studying Advanced Solid Tumor, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Jiangsu HengRui Medicine Co., Ltd., Novartis Pharmaceuticals, Shanghai YingLi Pharmaceutical Co. Ltd., among others.